Redhill Biopharma reported $24.66M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Cara Therapeutics CARA:US USD 34.66M 7.18M
Cronos Group Inc CRON:CN USD 80.9M 29.77M
Intra Cellular Therapies ITCI:US USD 127.5M 16M